Iluminage Beauty Uses Cognizant's MedVantage Cloud Platform to Improve 'At-Home' Aesthetic Care Experience

News provided by

Sep 10, 2015, 06:00 ET

TEANECK, N.J., Sept. 10, 2015 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that Iluminage Beauty Inc., a leader in at-home beauty care devices, has deployed the Cognizant MedVantage™ platform to proactively address customer feedback and better manage product quality and performance.

Iluminage Beauty, a joint venture between Unilever Ventures and Syneron, designs, develops and distributes at-home products derived from professional medical aesthetic devices for skin rejuvenation, hair removal, acne treatment and others.

Cognizant's cloud-based MedVantage solution will enable Iluminage to investigate complaints from across North America more effectively and efficiently, and create reports for enhanced regulatory compliance. It will help Iluminage improve customer and stakeholder responsiveness and accelerate decision-making by enabling separate handling of safety and non-safety complaints, delivering advanced analytics and providing a consistent view of data from multiple systems delivered by powerful real-time dashboards that can be accessed from anywhere.

Developed on the Salesforce1 platform, MedVantage is integrated with Iluminage's Salesforce.com customer relationship management (CRM) platform and compliant with the FDA's 21 CFR Part 11 Rule on electronic records.

"Iluminage is the new intelligence in beauty, architects of high-tech, ground breaking devices, treatments and textiles bringing tomorrow's technology into the hands of consumers at home," said Bo Kim, Vice President, Regulatory and Compliance at Iluminage. "Our objective is to deliver the highest level of at-home beauty care experience to our customers in North America and all over the world. With Cognizant MedVantage, our customer support and investigation teams can take a proactive approach to monitoring our quality and performance. It will help us better understand and improve our at-home beauty solutions while maintaining a high level of regulatory compliance through streamline reporting."

"With the rapid growth of at-home aesthetic devices once only available in professional environments, Iluminage is leveraging the power of the cloud with MedVantage to improve customer experience and ensure that complaints are effectively addressed," said Shankar Narayanan, Vice President and Global Markets Leader of the Life Sciences practice at Cognizant. "We developed MedVantage as a turnkey solution on Salesforce1 in order to provide the highest levels of integration with a leading cloud and CRM platform and enable companies to continue transforming into digital enterprises and be as agile and innovative as possible."

About Iluminage Beauty Inc.

Iluminage Beauty Inc. is a joint venture between Unilever Ventures and Syneron Medical. As architects of high-tech, groundbreaking treatments, textiles and devices, the company's portfolio of products are based upon clinically proven technologies derived from professional medical and aesthetic treatments, enabling consumers to achieve professional results at home. The iluminage brand portfolio includes the iluminage SKIN SMOOTHING LASER™, which launched in spring 2014, becoming the first at-home laser device FDA-cleared to reduce fine lines and wrinkles around the eyes and mouth; iluminageTOUCH, the first and only at-home hair removal device clinically proven and FDA-cleared to be safe and effective for all skin types and tones, as well as the widest range of hair colors; iluminage PRECISE TOUCH, a compact hair removal device intended for use on targeted treatment areas including the upper lip, underarms and bikini area; and intelligent textiles---pillowcases and eye masks infused with patented copper technology, which delivers overnight anti-aging care to help maintain the skin's youthful appearance.

About Cognizant's Healthcare and Life Sciences Practice

Cognizant's Healthcare and Life Sciences practice, which includes the TriZetto software portfolio, is committed to helping change millions of lives for the better by partnering with clients to build solutions to healthcare challenges, continually improve the way they do business, set the pace in clinical development, strengthen their regulatory infrastructure, and increase competitiveness. With over $3.5 billion in annualized revenue, Cognizant's healthcare practice is ranked among the top 5 on the Healthcare Informatics Top 100. Cognizant serves 28 of the top 30 global pharmaceutical companies, 16 of the top 20 health plans in the U.S., 3 of the top 5 pharmacy benefit management companies in the U.S., 9 of the top 10 biotech companies, and 12 of the top 15 medical device companies. With a large team of dedicated professionals including doctors, pharmacologists, physicians, biomedical engineers, pharmacists, biostatisticians, medical writers, and GxP consultants, the practice provides domain-aligned consulting, IT, business process, software and as-a-service solutions globally.

About Cognizant

Cognizant (NASDAQ: CTSH) is a leading provider of information technology, consulting, and business process outsourcing services, dedicated to helping the world's leading companies build stronger businesses. Headquartered in Teaneck, New Jersey (U.S.), Cognizant combines a passion for client satisfaction, technology innovation, deep industry and business process expertise, and a global, collaborative workforce that embodies the future of work. With over 100 development and delivery centers worldwide and approximately 218,000 employees as of June 30, 2015, Cognizant is a member of the NASDAQ-100, the S&P 500, the Forbes Global 2000, and the Fortune 500 and is ranked among the top performing and fastest growing companies in the world. Visit us online at www.cognizant.com or follow us on Twitter: Cognizant.

Logo - http://photos.prnewswire.com/prnh/20110329/NY67603LOGO

SOURCE Cognizant